Impact of Brokerage Rating on Illumina, Inc.(ILMN)

Many Illumina, Inc.(ILMN) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Company shares were Reiterated by UBS on Feb 1, 2017 to Buy, Raises Price Target to $ 185 from a previous price target of $180 .Illumina was Initiated by Deutsche Bank on Jan 18, 2017 to Hold, Price Target of the shares are set at $160.Illumina was Upgraded by BofA/Merrill to Buy on Jan 10, 2017. Illumina was Upgraded by CL King to Buy on Jan 6, 2017. Illumina was Reiterated by Morgan Stanley on Dec 7, 2016 to Underweight, Lowers Price Target to $ 100 from a previous price target of $115 .

Company has reported several Insider transactions to the SEC, on Feb 10, 2017, A Blaine Bowman (director) sold 3,000 shares at 162.98 per share price.On Feb 8, 2017, Charles Dadswell (Sr VP & General Counsel) sold 572 shares at 161.26 per share price.On Feb 6, 2017, Omead Ostadan (EVP Ops, Products, Strategy) sold 1,104 shares at 160.41 per share price.

Illumina Last issued its quarterly earnings results on Jan 31, 2017. The company reported $0.85 EPS for the quarter, beating the analyst consensus estimate by $ 0.02. Analyst had a consensus of $0.83. The company had revenue of $619.00 million for the quarter, compared to analysts expectations of $614.41 million. The companys revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.81 EPS.

Illumina, Inc. (NASDAQ:ILMN) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 2.43 by 17 Brokerage Firm. 7 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 6 Brokerage Firms have advised hold. 3 Analysts have rated it as strong sell.

Illumina, Inc. (NASDAQ:ILMN) should head towards $152.44 per share according to 16 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $100 per share. The higher price estimate target is at $185 according to the Analysts.

Illumina, Inc. (NASDAQ:ILMN) rose 0.38% or 0.62 points on Tuesday and made its way into the gainers of the day. After trading began at $164.21 the stock was seen hitting $165.69 as a peak level and $163.15 as the lowest level. The stock ended up at $164.46. The daily volume was measured at 765,700 shares. The 52-week high of the share price is $186.88 and the 52-week low is $119.37. The company has a market cap of $24,159 million.

Illumina Inc. is a leading developer of next-generation tools for the large-scale analysis of genetic variation and function. The companys tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.


Share this post

Leave a Reply